Enterome Announces Positive Preliminary Trial Data for Non-Hodgkin Lymphoma
mcmurryjulie / Pixabay

Enterome Announces Positive Preliminary Trial Data for Non-Hodgkin Lymphoma

  Enterome presented its findings to the 17th International Conference on Malignant Lymphoma (ICML) in June of this year. As reported in the GlobeNewswire, the company demonstrated that E02463 together…

Continue Reading Enterome Announces Positive Preliminary Trial Data for Non-Hodgkin Lymphoma
A Preview of Potentially Historic FDA Approvals for 2023
source: shutterstock.com

A Preview of Potentially Historic FDA Approvals for 2023

  The later part of 2023 will see decisions on drugs in four areas such as advanced melanoma, sickle cell disease, Alzheimer’s disease, and depression. BioSpace shines the spotlight on…

Continue Reading A Preview of Potentially Historic FDA Approvals for 2023